Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

O preço da ação Voyager Therapeutics, Inc. Common Stock (VYGR) hoje é de , refletindo uma movimentação de NaN% desde que o mercado abriu. A capitalização de mercado da empresa é de $ 227,96 mi, com um volume comercial diário de  ações. O preço de fechamento anterior foi .

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Voyager Therapeutics ações na Kraken a partir de US$ 10.